Green Square Capital Advisors LLC Landos Biopharma, Inc. Transaction History

Green Square Capital Advisors LLC

  • $723 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 14, 2023
SELL
$0.26 - $0.55 $21,970 - $46,475
-84,500 Reduced 89.42%
10,000 $3,000
Q4 2022

Feb 15, 2023
BUY
$0.22 - $0.51 $2,200 - $5,100
10,000 Added 11.83%
94,500 $47,000
Q3 2022

Oct 31, 2022
BUY
$0.67 - $1.26 $56,615 - $106,470
84,500 New
84,500 $55,000

About Landos Biopharma, Inc.

LABP Quotes by TradingView
  • Ticker LABP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,254,900
  • Description
  • Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...
More about LABP
Track This Portfolio

Track Green Square Capital Advisors LLC Portfolio

Follow Green Square Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Green Square Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Green Square Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email